Prevention of diagnostic and treatment-related sequelae in stage I and II Hodgkin's disease

被引：0
|
作者：
Cox, JD [1 ]
Ha, CS [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
来源：
RADIATION INJURY: ADVANCES IN MANAGEMENT AND PREVENTION | 1999年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 97
页数：13
相关论文
共 50 条
  • [31] Prevention of treatment-related side effects in hematology
    Guieze, Romain
    Renneville, Aline
    Yakoub-Agha, Ibrahim
    Coiteux, Valerie
    Bauters, Francis
    Facon, Thierry
    Leleu, Xavier
    HEMATOLOGIE, 2005, 11 (01): : 81 - 90
  • [32] Primary non-Hodgkin's lymphoma of the bone: Treatment and analysis of prognostic factors for stage I and stage II
    Barbieri, E
    Cammelli, S
    Mauro, F
    Perini, F
    Cazzola, A
    Neri, S
    Bunkheila, F
    Ferrari, S
    Brandoli, V
    Zinzani, P
    Mercuri, M
    Bacci, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (03): : 760 - 764
  • [33] Treatment-related risk factors for premature menopause following Hodgkin's lymphoma.
    De Bruin, M. L.
    Huisbrink, J.
    Aleman, B. M.
    Van Leeuwen, F. E.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 47 - 47
  • [34] Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients
    Armitage, JO
    Carbone, PP
    Connors, JM
    Levine, A
    Bennett, JM
    Kroll, S
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) : 897 - 906
  • [35] Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease
    André, M
    Henry-Amar, M
    Blaise, D
    Colombat, P
    Fleury, J
    Milpied, N
    Cahn, JY
    Pico, JL
    Bastion, Y
    Kuentz, M
    Nedellec, G
    Attal, M
    Fermé, C
    Gisselbrecht, C
    BLOOD, 1998, 92 (06) : 1933 - 1940
  • [36] Hodgkin disease in children: Reduced tailored chemotherapy for stage I-II disease
    Yaniv, I
    Saab, A
    Cohen, IJ
    Goshen, Y
    Loven, D
    Stark, B
    Tamary, H
    Zaizov, R
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1996, 18 (01) : 76 - 80
  • [37] More than 4 cycles of ABVD for the treatment of stage I-II Hodgkin's lymphoma?
    Tartas, N
    Zerga, M
    Alfonso, G
    Copello, MPA
    Santos, I
    Korin, J
    Nucifora, E
    Fantl, D
    Luchetta, P
    Ferro, H
    Chacón, C
    Barazzutti, L
    Scoles, A
    Rainieri, F
    Alberbide, J
    VijnovichBarón, A
    Kusminsky, G
    Foncuberta, M
    Avalos, JS
    BLOOD, 2005, 106 (11) : 260B - 260B
  • [38] Mid-term treatment-related cognitive sequelae in glioma patients
    Schloemer, Sabine
    Felsberg, Joerg
    Pertz, Milena
    Hentschel, Bettina
    Loeffler, Markus
    Schackert, Gabriele
    Krex, Dietmar
    Juratli, Tareq
    Tonn, Joerg Christian
    Schnell, Oliver
    Vatter, Hartmut
    Simon, Matthias
    Westphal, Manfred
    Martens, Tobias
    Sabel, Michael
    Bendszus, Martin
    Doerner, Nils
    Fliessbach, Klaus
    Hoppe, Christian
    Reifenberger, Guido
    Weller, Michael
    Schlegel, Uwe
    JOURNAL OF NEURO-ONCOLOGY, 2022, 159 (01) : 65 - 79
  • [39] Mid-term treatment-related cognitive sequelae in glioma patients
    Sabine Schlömer
    Jörg Felsberg
    Milena Pertz
    Bettina Hentschel
    Markus Löffler
    Gabriele Schackert
    Dietmar Krex
    Tareq Juratli
    Joerg Christian Tonn
    Oliver Schnell
    Hartmut Vatter
    Matthias Simon
    Manfred Westphal
    Tobias Martens
    Michael Sabel
    Martin Bendszus
    Nils Dörner
    Klaus Fliessbach
    Christian Hoppe
    Guido Reifenberger
    Michael Weller
    Uwe Schlegel
    for the German Glioma Network
    Journal of Neuro-Oncology, 2022, 159 : 65 - 79
  • [40] Prevention of treatment-related ovarian damage in young women with Hodgkin's lymphoma (HL) by gonadotropin-releasing hormone analogue (GnRHa)
    Falorio, S.
    Angrilli, F.
    Fioritoni, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 245 - 245
12345